Global Ganja Report

Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)

In a last-minute move before the measure was to automatically become law, Gov. Greg Abbott on June 23 vetoed Senate Bill 3, which sought to ban the sale of all THC-laden products in Texas, whether Delta-8 and Delta-9. The bill would have also placed greater restrictions on CBD products, such as banning their sale to those under 21. Abbott has called for a special legislative session to revisit the question, which has pitted the hemp industry against the GOP establishment. Abbott's own Lt. Gov. Dan Patrick was a key advocate of the "THC ban." Patrick bashed Abbott over the veto, saying he "wants to legalize recreational marijuana."

In the big — and, in nearly half of US states now, successful — drive to legalize cannabis, two major arguments have been brought to bear. First, that public oversight of a legal industry will assure transparency and standards for quality. And secondly, that a taxed industry will be a boon to state and local economies.

But now a disturbing new study from an industry advocacy group in California indicates that the legal cannabis sector faces a challenge in the proliferation of ostensibly legal but in fact unregulated psychoactive “hemp” products.

Rights for medicinal cannabis users in the workplace have not kept pace with the law in states that have embraced medical and even “recreational” use. Now a case in Vermont may push state and federal authorities alike to close the loopholes that allow workers to be dismissed—and denied unemployment insurance—for using state-legal medicine.

Raphael Mechoulam, the ground-breaking cannabis researcher who first isolated and identified THC in 1964, died in Israel at the age of 92. His passing was announced March 10 by Jerusalem's Hebrew University, where Mechoulam co-founded the Multidisciplinary Center for Cannabinoid Research in 2017.

Despite a heretofore uninspiring record, Biden is poised to complete a trifecta of long-sought reforms of federal cannabis law: giving the industry access to financial services, expungement of convictions for possession, and allowing medical research.

The legalization of hemp-derived cannabinoids by the 2018 Farm Bill has left a yawning regulatory gap that is being avidly exploited by purveyors of high-potency edibles and sketchy vape products.


That's the contention of a report just issued by the leading California cannabis trade group, warning that the law inadvertently opened a "Pandora's box" that poses threats to public health.

Small is Beautiful for the Berkshires’ Badass Bud

Nestled in the Berkshire Mountains of western Massachusetts is the town of West Stockbridge, where Wiseacre Farm boasts that it is the smallest artisanal cannabis producer in the commonwealth.